1. Home
  2. Research
  3. Research Groups
  4. Translational lung cancer research group

Translational lung cancer research group

The Lung Cancer Translational Research Group (GITCaP) is dedicated to the research and treatment of thoracic tumors, with a multidisciplinary team of oncologists, surgeons, pathologists, radiologists, pulmonologists and other specialists. Their lines of research focus on identifying predictive markers of treatment efficacy and improving patient survival and quality of life. In addition, they collaborate in clinical trials and projects on microbiota, blood biomarkers, cancer in non-smokers and the impact of radon. They also investigate the use of artificial intelligence in radiology and the promotion of physical exercise to reduce inflammation.

Search for projects

Only competitive projects.

R&D Projects

  • BECAS SEOM 2023_ONCOLOGIA MEDICA_GARCIA MIGUEL

    Principal Investigator
    PILAR GARRIDO LÓPEZ, MIGUEL GARCÍA PARDO DE SANTAYANA
    Code
    2024/0042
    Start year
    2024
    End year
    2025
    Funding body
    SOCIEDAD ESPAÑOLA DE ONCOLOGIA MEDICA

  • PREMIUM PROJECT: (PRedicting ExtreMe response to Immunotherapy in lUng cancer through Microbiota fingerprint))

    Principal Investigator
    PILAR GARRIDO LÓPEZ
    Call
    AES 2022. PROYECTOS DE I+D+I EN SALUD
    Code
    PI22/01584
    Start year
    2023
    End year
    2025
    Funding body
    INSTITUTO DE SALUD CARLOS III

Non commercial Clinical Trials

  • Trasplante de microbiota en cáncer de pulmón avanzado tratado con inmunoterapia: Estudio MORELIA

    Principal Investigator
    SERGIO SERRANO VILLAR, PILAR GARRIDO LÓPEZ
    Call
    AES 2020. Proyectos de Investigación Clínica Independiente (ICI)
    Code
    ICI20/00058
    Start year
    2021
    End year
    2024
    Funding body
    INSTITUTO DE SALUD CARLOS III, FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
    Co-funded
    Fondo Europeo de Desarrollo Regional (FEDER)

Human Resources

  • Medicina de precisión en inmunoterapia: Identificación de biomarcadores predictivos de toxicidad inmuno-relacionada.

    Principal Investigator
    PILAR GARRIDO LÓPEZ
    Call
    AECC. CLINICO JUNIOR EN EL TERRITORIO AECC 2024
    Code
    2024/0189
    Start year
    2024
    End year
    2028
    Funding body
    FUNDACIÓN CIENTÍFICA DE LA ASOCIACIÓN ESPAÑOLA CONTRA EL CÁNCER

  • PRedicting ExtreMe response to Immunotherapy in lUng cancer through Microbiota fingerprint (PREMIUM PROJECT)

    Principal Investigator
    PILAR GARRIDO LÓPEZ
    Call
    AECC. CLINICO JUNIOR EN EL TERRITORIO AECC 2023
    Code
    2023/0003
    Start year
    2023
    End year
    2026
    Funding body
    FUNDACIÓN CIENTÍFICA DE LA ASOCIACIÓN ESPAÑOLA CONTRA EL CÁNCER